Home/Filings/4/0000950170-23-072755
4//SEC Filing

SUMER JACQUELYN L 4

Accession 0000950170-23-072755

CIK 0001789972other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 5:30 PM ET

Size

5.3 KB

Accession

0000950170-23-072755

Insider Transaction Report

Form 4
Period: 2023-12-21
SUMER JACQUELYN L
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2023-12-21$8.50/sh1,400$11,90044,133 total
Footnotes (2)
  • [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.49 to $8.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001844824

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:30 PM ET
Size
5.3 KB